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*e aim of the study was to examine the oral health status of Parkinson’s disease (PD) patients, to compare their oral health status
to that of a control group, and to relate it to the duration and severity of PD. Materials and Methods. 74 PD patients and 74
controls were interviewed and orally examined. Among PD patients, the duration and the Hoehn and Yahr stage (HY) of the
disease were registered. Results. More PD patients than controls reported oral hygiene care support as well as chewing/biting
problems, taste disturbance, tooth mobility, and xerostomia, whereas dentate patients had more teeth with carious lesions, tooth
root remnants, and bioﬁlm. Both longer duration and higher HY were associated with more chewing problems and, in dentates,
more teeth with restorations. In dentates, longer duration of the disease was associated with higher number of mobile teeth.
Higher HYwas associated with more oral hygiene care support as well as biting problems and, in dentates, more teeth with carious
lesions and tooth root remnants. Conclusions. Comparatively, PD patients had weakened oral health status and reduced oral
hygiene care. Both duration and severity of the disease were associated with more oral health and hygiene care problems.
1. Introduction
Parkinson’s disease is a progressive degenerative neurological
disorder, characterized by motor and nonmotor symptoms.
*e motor symptoms include akinesia, bradykinesia, rigidity,
and tremor, which remain not restricted to the trunk and
extremities, but may also occur in the orofacial system [1–3].
Motor impairments of the orofacial system include dysphagia,
masticatory dysfunction, orofacial dyskinesia, and oro-
mandibular dystonia [4–7]. In addition, related to oral health,
the potentially impaired dexterity of arms and ﬁngers may
hamper the required daily oral hygiene care [8].
Advances in oral health care and treatment during the
past few decades have resulted in a reduced number of
edentulous individuals. *e proportion of adults who retain
their teeth until late in life has increased substantially [9].
Consequently, a still increasing number of dentate older
people experience oral health problems, such as dental caries,
periodontal disease, and substantial wear of hard tooth tissues
(tooth wear). Furthermore, many older people have been
treated with oral implants and/or sophisticated tooth- and/or
implant-supported ﬁxed and/or removable dental prostheses.
Hence, these older people are in continuous need of both
preventive and curative oral health care. *e complexity of
oral health status, the potential presence of systemic diseases,
and the use of several medications make older people more
vulnerable to oral problems when compared to younger age
groups, particularly in those who are cognitively impaired
[10, 11]. In addition, weakened oral health due to neglected
oral hygiene care and reduced oral health care utilization has
previously been found in older people [11–14].
Oral diseases, such as dental caries and periodontal
disease, not only have oral eﬀects, for example oral pain and
oral functioning problems, but may also impact a number of
systemic conditions. Emerging evidence suggests that poor
oral health inﬂuences the initiation and/or progression of
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diseases, such as atherosclerosis, diabetes mellitus, Alz-
heimer’s disease, and rheumatoid arthritis [15]. Aspiration
of oropharyngeal bacteria may cause pneumonia [15–17].
Concerns were expressed about relationships between older
people’s poor oral health status and nutrition [18].
Study of the international literature revealed that, when
compared to control subjects, Parkinson’s disease patients
generally had a lower number of teeth, more dental carious
lesions, poorer periodontal health, higher objective peri-
odontal treatment needs, more subjective chewing diﬃculties,
more subjective swallowing diﬃculties, more subjective
denture discomfort, more limited active mouth opening, and
more negative impact of oral health on daily life (Table 1)
[19–28]. However, each of the aforementioned studies in-
vestigated only few aspects of oral health; none investigated
the whole picture of the oral health status. Furthermore, the
relationships between aspects of oral health and the duration
and severity of Parkinson’s disease have not been addressed.
*erefore, the aim of the current study was to examine
the most relevant aspects of the subjective and objective oral
health status of Parkinson’s disease patients, to compare
their oral health status to that of an optimally gender-, age-,
social background-, and lifestyle-matched control group,
and to relate their oral health status to the duration and
severity of Parkinson’s disease.
2. Materials and Methods
2.1. Study Population. *e current cross-sectional, case-
control, optimally gender-, age-, social background-, and
lifestyle-matched study was approved by the Medical Ethical
Committee of Leiden University Medical Center, Leiden, the
Netherlands, approval number P13.079. Assuming a power
(1-β) of 0.80 and an α of 0.05 and an objective to detect
a prevalence diﬀerence of 25% between groups across a range
of diﬀerent hypothetical prevalence rates, a sample size cal-
culation indicated that 69 persons per group of Parkinson’s
disease patients and control subjects would be suﬃcient.
Patients with Parkinson’s disease, without severe
comorbidity according to classes III and IV of the Physical
Status Classiﬁcation System of the American Society of
Anesthesiologists, were requested to participate when they
visited the Department of Neurology of the Leiden Uni-
versity Medical Center, Leiden, the Netherlands, for a rou-
tine periodic consultation. *e Parkinson’s disease patients
who agreed to participate, were subsequently requested to
identify a control person, for instance a family member or
other close relative, who had no Parkinson’s disease or other
severe systemic diseases according to classes III and IV of the
Physical Status Classiﬁcation System of the American So-
ciety of Anesthesiologists, who had approximately the same
age (±5 years) as well as a similar social background and
lifestyle, and who would likely be prepared to participate.
*e group of control subjects was also optimally gender
matched, meaning that men with Parkinson’s disease
preferably indicated men and women with Parkinson’s
disease preferably indicated women. Assuming that not
every person proposed by a Parkinson’s disease patient as
control subject would agree to participate, initially 74
Parkinson’s disease patients were included. All Parkinson’s
disease patients and indicated control subjects were visited at
their homes to inform them about the research project.
Luckily, all of them provided informed consent and were
subsequently interviewed and examined.
After the interview and the examination, every partici-
pant received information on his/her actual oral health
condition and was recommended consultation with a dentist
in case the actual oral health condition required attention
and/or treatment.
2.2. Assessments. Using a common history form, data were
gathered about educational level (primary, secondary, and
tertiary), smoking habits, length of time since the last oral
health consultation, number of oral health consultations
during the previous ﬁve years, daily oral hygiene care
(whether or not supported by a professional or voluntary care
provider), type of toothbrush used, chewing problems, biting
problems, taste disturbance, burning mouth, xerostomia,
halitosis, remaining food particles, tooth mobility, toothache,
tooth sensitivity, painful gums, and bleeding gums. Persons
with an edentulous maxilla/mandible were requested to in-
dicate the duration since the last teeth in themaxilla/mandible
had been removed, the number of years during which
a current complete maxillary/mandibular removable dental
prosthesis was functioning, and their potential experience
with a loose coming complete maxillary/mandibular re-
movable dental prosthesis during oral movements.
An experienced dentist performed an oral health ex-
amination in all participants, using a common oral screening
form. Variables included were edentulousness, soft tissue
lesions, complete or partial maxillary/mandibular removable
dental prostheses, number of teeth, number of teeth with
carious lesions, number of teeth with restorations, number
of tooth root remnants, amount of bioﬁlm and food, peri-
odontal health, and number of posterior functional tooth
units, including (implant-supported) single- and multiunit
ﬁxed dental prostheses.
*e amount of bioﬁlm and food on teeth and soft tissues
was assessed by a simple 3-points scale: 1� hardly any
bioﬁlm and food; 2� thin layer of bioﬁlm and food; 3� thick
layer of bioﬁlm and food.
Periodontal health was assessed using the tooth mobility
scoring system. *is clinically easy-to-determine system
diﬀerentiates three grades: grade I: mobility in a horizontal
direction more than 0.2mm and less than 1mm; grade II:
mobility in a horizontal direction of 1mm or more; and
grade III: mobility in vertical direction [29].
*e number of posterior functional tooth units is an
important proxy for masticatory eﬃciency. One maxillary
and one mandibular premolar in occluding contact con-
stitute one posterior functional tooth unit. One occluding
maxillary and mandibular molar are equivalent to two
posterior functional tooth units [30].
In persons with an edentulous maxilla/mandible, the
reduction of the edentulous residual alveolar ridge was
clinically classiﬁed as moderate reduction, high degree of
reduction, or extensive reduction, using a standard set of
edentulous alveolar ridge models [31].
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For Parkinson’s disease patients, the duration of the
disease (since the onset of motor symptoms) and the severity
of the disease expressed by the Hoehn and Yahr stage were
registered from the patients’ medical records [32]. *e
duration of the disease was categorized as less than 5 years,
between 5 and 9 years, and 10 years or longer.
2.3. Statistical Analysis. Data were analyzed using SPSS
version 22.0 (SPSS, Inc., Chicago, IL). Numbers and per-
centages were compared between groups using a Chi-square
test (χ2). An independent-samples Student’s t-test was only
used to compare the age of Parkinson’s disease patients and
control subjects. Mann–WhitneyU test was used to compare
Table 1: Studies on Parkinson’s disease and oral health, available in the international literature.
Publication Country Research design Population Results of PD patients whencompared to controls OR 95% CI P
Nakayama et al.,
2004 [19] Japan
Questionnaire
survey by mail
104 with PD
191 controls
Gender- and age-adjusted:
More chewing diﬃculties 6.0 2.8–12.8
More denture discomfort 3.9 1.9–8.0
More edentulousness 3.5 1.8–6.8
Less daily denture care 10.5 2.9–37.3
50% swallowing problems
Schwarz et al.,
2006 [20] Germany
Case-control,
age-matched
70 with PD
85 controls
Higher scores on indices of the
Community Periodontal Index for
Treatment Needs (CPITN)
<0.05
Einarsdo´ttir et al.,
2009 [21] Iceland Case-control
67 with PD
55 controls
Lower number of teeth <0.036
More dental carious lesions <0.007
More bioﬁlm 3.13 1.4–6.9 <0.004
Poorer periodontal health 2.28 1.0–4.9 0.035
Greater number of cariogenic
bacteria in saliva <0.05
Hanaoka and
Kashihara,
2009 [22]
Japan Case-control,age-matched
89 with PD
68 mild cognitively
impaired
60 with ischemic
stroke
Lower number of teeth <0.05
More dental carious lesions <0.001
More deep periodontal <0.001
pockets
Bakke et al.,
2011 [23] Denmark
Case-control,
age-matched,
gender-matched
15 with moderate
to advanced PD
15 controls
Overall objective orofacial function <0.001
Poorer subjective masticatory
ability <0.001
Poorer active mouth opening <0.001
More negative impact of oral
health on daily life <0.001
Mu¨ller et al.,
2011 [24] Germany Case-control
101 with PD
75 controls
Lower gingival index <0.001
Lower frequency of daily tooth
brushing <0.01
More dental carious lesions <0.01
Longer time since last dental visit <0.001
Lower salivary ﬂow rate <0.001
More gingival recession <0.001
More tooth mobility <0.001
Cicciu` et al.,
2012 [25] Italy
Case-control,
age-matched
45 with mild to
moderate PD
45 controls
More dental carious lesions not reported
Higher gingival index not reported
Higher sulcus bleeding index not reported
Higher bioﬁlm index not reported
Pradeep et al.,
2015 [26] India
Case-control,
age-matched
45 with PD
46 controls
More periodontal pockets <0.001
More periodontal attachment loss <0.001
Lower gingival index <0.001
Lower bioﬁlm index <0.001
Ribeiro et al.,
2016 [27] Brasil Case-control
Wearers of complete
removable dental
prostheses 17 with PD
20 controls
Poorer self-perception of oral
health <0.04
Barbe et al.,
2017 [28] Germany
Questionnaire
survey
100 with PD
Frequencies compared
with results of other
studies
Poorer oral health impact proﬁle,
among others due to complaints
of xerostomia, drooling and
dysphagia
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ordinal or nonnormally distributed continuous variables
between groups. Kruskal–Wallis test was used to examine
group diﬀerences of nonnormally distributed continuous
variables with three or more categories. Statistical signiﬁ-
cance was accepted at P< 0.05. Given the exploratory
character of the study, no attempt was made to control for
multiple comparisons.
3. Results
3.1. Participants. Interviews and oral health examinations
were performed in 26 women and 48 men with Parkinson’s
disease and in 35 female and 39 male control subjects
(χ2(1) � 2.259, P � 0.133). Mean age± standard deviation
was 70.2± 8.8 years in the Parkinson’s disease patients and
67.9± 10.1 years in the control subjects (Student’s t-test;
P � 0.641).
3.2. Subjective Variables. Table 2 presents frequencies and
percentages of the subjective variables of the Parkinson’s
disease patients and the control subjects. When compared to
the control subjects, statistically signiﬁcantlymore Parkinson’s
disease patients reported daily oral hygiene care support by
a professional or voluntary care provider, chewing problems,
biting problems, taste disturbance, and xerostomia. When
compared to the dentate control subjects, statistically signif-
icantly more dentate Parkinson’s disease patients reported
tooth mobility.
*e Parkinson’s disease patients and control subjects
with an edentulous maxilla (and mandible) showed no
statistically signiﬁcant group diﬀerences with regard to
length of time since the last teeth had been removed, number
of years during which a current complete maxillary/
mandibular removable dental prosthesis was functioning,
and persons’ experiences with a loose coming complete
maxillary/mandibular removable dental prosthesis during
oral movements.
3.3. Objective Variables. Table 3 presents frequencies and
percentages of the objective variables of the Parkinson’s
disease patients and the control subjects. Statistical analysis
of the data of dentate persons did point out that the
Table 2: Frequencies, including percentages, of the general subjective aspects of oral health and the often/occasional oral health complaints
of the (dentate) Parkinson’s disease patients (PD) and the (dentate) control subjects (control) and the results of the Chi-square test carried
out to assess statistically signiﬁcant diﬀerences (∗) between PD and control.
Variables PD Control Chi-square test
All persons: general subjective variables n � 74 n � 74
Educational level
(i) primary 18 (24%) 12 (16%)
(ii) secondary 21 (29%) 35 (47%)
(iii) tertiary 34 (46%) 27 (37%)
(iv) missing value 1 (1%) — χ2(7) � 11.947; P � 0.102
Smoking status 6 (8.1%) 6 (8.1%) —
Length of time since the last oral health consultation
(i) less than half a year 52 (70.3%) 49 (66.2%)
(ii) between a half and two years 15 (20.3%) 22 (29.8%) χ2(5) � 5.704; P � 0.336
Number of oral health consultations during the previous ﬁve years
(i) 0 4 (5.4%) 2 (2.7%)
(ii) 1–5 13 (17.6%) 17 (23.0%)
(iii) 6–10 30 (40.5%) 36 (48.6%)
(iv) 11 or more 27 (36.5%) 19 (25.7%) χ2(6) � 6.607; P � 0.359
Daily oral hygiene care supported by a professional or voluntary
care provider 11 (14.9%) 1 (1.4%) χ
2
(1) � 9.069; P � 0.003
∗
Electric toothbrush used 36 (48.6%) 30 (40.5%) χ2(3) � 3.091; P � 0.378
All persons: oral health complaints n � 74 n � 74
Chewing problems 22 (29.7%) 3 (4.1%) χ2(4) � 18.973; P � 0.001
∗
Biting problems 26 (35.1%) 7 (9.5%) χ2(4) � 15.047; P � 0.005
∗
Taste disturbance 17 (23.0%) 1 (1.4%) χ2(4) � 19.523; P � 0.001
∗
Burning mouth 3 (4.1%) 0 χ2(4) � 8.0290; P � 0.091
Xerostomia 48 (64.9%) 24 (32.4%) χ2(4) � 19.510; P � 0.001
∗
Halitosis 14 (18.9%) 9 (12.2%) χ2(4) � 7.037; P � 0.134
Remaining food particles 52 (70.3%) 51 (68.9%) χ2(4) � 2.877; P � 0.579
Dentate persons: oral health complaints n � 65 n � 65
Tooth mobility 12 (18.5%) 2 (3.1%) χ2(3) � 11.215; P � 0.011
∗
Toothache 10 (15.4%) 6 (9.2%) χ2(3) � 2.000; P � 0.572
Tooth sensitivity 17 (26.2%) 11 (16.9%) χ2(4) � 4.500; P � 0.343
Painful gums 12 (18.5%) 7 (10.8%) χ2(4) � 2.810; P � 0.590
Bleeding gums 13 (20.0%) 12 (18.5%) χ2(4) � 5.826; P � 0.213
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Parkinson’s disease patients had statistically signiﬁcantly
more teeth with carious lesions, a greater number of tooth
root remnants, and a greater amount of bioﬁlm and food
when compared to the control subjects.
Only few Parkinson’s disease patients and control
subjects had teeth with grades II and III of tooth mobility, 11
and 6 persons, respectively. *erefore, comparisons of
periodontal health between Parkinson’s disease patients and
control subjects were not performed.
*e persons who had an edentulous maxilla/mandible,
showed no statistically signiﬁcant diﬀerences between Par-
kinson’s disease patients and control subjects with regard to
grades of reduction of the edentulous residual alveolar ridges.
3.4. Parkinson’s Disease Patients. *e distribution of the
Parkinson’s disease patients across duration and Hoehn and
Yahr stage of the disease is presented in Table 4.
*e mean duration of the disease was 9.1± 6.4 years.
Reported chewing problems were statistically signiﬁ-
cantly positively related to the duration of the disease
(χ2(8) � 17.690, P � 0.024). In dentate patients, the number
of teeth with restorations and the number of teeth with
mobility grade II or III were statistically signiﬁcantly related
to the duration of the disease (Kruskal–Wallis test; resp.
H(2) � 6.398, P � 0.041 and H(2) � 8.058, P � 0.018).
For subsequent statistical analysis, the Hoehn and Yahr
stages were dichotimized, resulting in a group of 47 patients
with themild stages 1 and 2 and a group of 27 patients with the
moderate/severe stages 3, 4, and 5. *e reported chewing and
biting problems as well as the reported daily support for oral
hygiene care by a professional or voluntary care provider were
statistically signiﬁcantly positively related to the Hoehn and
Yahr stage of the disease (resp. χ2(4) � 14.045, P � 0.007;
χ2(4) � 10.939, P � 0.027; χ
2
(1) � 11.457, P � 0.001). Fur-
thermore, the number of teeth with carious lesions, the
number of teeth with restorations, and the number of tooth
root remnants appeared statistically signiﬁcantly higher in
dentate patients with the moderate/severe Hoehn and Yahr
stages 3–5, when compared to dentate patients with the
mild Hoehn and Yahr stages 1-2 (Mann–Whitney U test;
resp., U � 246.500, P � 0.001; U � 252.500, P � 0.004;
U � 311.000, P � 0.002).
4. Discussion
*is is the ﬁrst study which examined the most relevant
aspects of the subjective as well as the objective oral health
status of a large group of Parkinson’s disease patients, which
compared these ﬁndings with the same data of an optimally
gender-, age-, social background-, and lifestyle-matched
control group and which related the oral health status
of the Parkinson’s disease patients to the duration and se-
verity of the disease. *e ﬁndings demonstrate that more
Parkinson’s disease patients than control subjects reported
daily oral hygiene care support by a professional or vol-
untary care provider, as well as chewing problems, biting
problems, taste disturbance, tooth mobility, and xerostomia.
Objectively, the dentate Parkinson’s disease patients had
a greater number of teeth with carious lesions, a greater
Table 3: Frequencies, including percentages, of the objective oral health variables of the Parkinson’s disease patients (PD) and the control
subjects (control) and statistically signiﬁcant group diﬀerences.
Variables PD Control Statistical test
All persons n � 74 n � 74
Number of persons with an edentulous maxilla 14 (18.9%) 14 (18.9%)
Number of persons with an edentulous maxilla and mandible 9 (12.2%) 9 (12.2%)
Number of persons with a soft tissue lesion 20 (27.0%) 18 (24.3%)
Number of complete maxillary removable dental prostheses 14 15
Number of complete mandibular removable dental prostheses 9 9
Number of partial maxillary removable dental prostheses 8 7
Number of partial mandibular removable dental prostheses 10 9
Dentate persons n � 65 n � 65
Mean number of teeth 21.2 22.5
Number of teeth with carious lesions 74 12 Mann–Whitney U test; U � 1526.500,
P≤ 0.001
Number of teeth with restorations 466 518
Number of tooth root remnants 24 5 Mann–Whitney U test; U � 1818.000,
P< 0.022
Amount of bioﬁlm and food (scores 2 and 3) 39 (60%) 20 (31%) χ2(2) � 18.127; P< 0.001
Mean number of posterior functional tooth units, including
(implant-supported) single- and multiunit ﬁxed dental prostheses 3.2 2.8
Table 4: Distribution, including percentages, of the Parkinson’s
disease patients by duration (D) and Hoehn & Yahr stage (HY) of
the disease.
D/HY Number of patients Percentage
D less than 5 years 20 27
D between 5 and 9 years 19 26
D 10 years or more 35 47
HY1 16 22
HY2 31 42
HY3 11 14
HY4 12 16
HY5 4 6
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number of tooth root remnants, and a greater amount of
bioﬁlm and food, when compared to the dentate control
subjects. *ese ﬁndings represent symptoms of weakened
oral health and reduced oral hygiene care, probably due to
Parkinson’s disease impairments. Within the group of
Parkinson’s disease patients, both longer duration and
higher Hoehn and Yahr stage of the disease were associated
with more chewing problems and, in dentate persons, with
more teeth with restorations. Additionally, in dentate per-
sons, longer duration of the disease was associated with
a higher number of teeth with mobility grade II or III,
whereas a higher Hoehn and Yahr stage of the disease was
associated with more daily oral hygiene care support by
a care provider as well as biting problems and, in dentate
persons, with more teeth with carious lesions and more
tooth root remnants. *ese ﬁndings reﬂect symptoms of
weakening oral health, probably due to the reducing ability
to manage oral hygiene care as the disease advances.
Existing data on the oral health of Parkinson’s disease
patients, as presented in Table 1, are extended by the results
of the current study. Novel identiﬁed oral health problems
include taste disturbance and more oral health problems in
advanced stages of the disease. Together, these data indicate
that weakening oral health and its potential negative impact
on several systemic conditions are serious problems in
Parkinson’s disease patients, which demand more attention
worldwide by the multidisciplinary Parkinson’s disease
medical management teams as well as standard referrals to
oral health-care providers.
Chewing and biting problems, more reported by Par-
kinson’s disease patients than control subjects, pre-
dominantly in advanced stages of the disease, may reﬂect
(increasing) motor impairments of the orofacial system.
Consequently, it is recommended to consider research of
chewing and biting problems in Parkinson’s disease patients
with the objective to manage or reduce these problems.
Other impairments of the orofacial system of Parkinson’s
disease patients may present as temporomandibular dys-
function. A recent study among a group of Parkinson’s
disease patients found temporomandibular dysfunction in
about one-ﬁfth of the patients [33]. Nevertheless, since
diagnosing and classifying temporomandibular dysfunction
is a rather complicated and time-consuming activity [34], we
decided consciously not to include temporomandibular
dysfunction as a research variable in our study. A separate
and speciﬁc study on this topic is in preparation by the
research groups involved in the current study.
When considered in relation to oral health, taste distur-
bance is certainly a novel ﬁnding in Parkinson’s disease patients
since none of the studies mentioned in Table 1 reported this
problem. However, olfactory loss as well as smell and taste loss
are well-known neurological problems in Parkinson’s disease.
Results of a recent (neurological) study suggest that the
problems are caused by a decline of central brain networks
rather than a damage of the peripheral olfactory system [35].
Previously, the olfactory deﬁcit was demonstrated to be in-
dependent of Parkinson’s disease severity and duration and
preceding clinical motor symptoms by years. For this reason,
taste disturbance was even suggested to be used for assessing
the risk of Parkinson’s disease in otherwise asymptomatic
individuals [36]. From an oral health perspective, taste ability
may change due to deterioration of oral health status, deﬁcient
oral hygiene, and impaired masticatory ability [37]. Addi-
tionally, saliva is of great importance since it acts as a solvent of
taste substances, aﬀects taste sensitivity, and maintains the
health and function of the taste receptors. Consequently,
hyposalivation results, among others, in signiﬁcant altered taste
sensation or taste disturbance [38]. Hyposalivation may induce
oral health problems, such as toothwear, oral soft tissue lesions,
dental caries, candidiasis, and periodontal disease [39]. Nearly
65% of the Parkinson’s disease patients in our study reported
xerostomia (Table 2), conﬁrming previous results demon-
strating or suggesting that xerostomia and the commonly
underlying hyposalivation are prevalent complications of
Parkinson’s disease [28, 40]. Another saliva complication of
Parkinson’s disease patients is drooling. Most likely, impaired
intraoral saliva clearance is the basis of its pathophysiology.
However, research to explore the exact pathophysiology and to
develop standard diagnostic criteria and assessment tools are
needed [41]. *erefore, taste disturbance, xerostomia, hypo-
salivation, and drooling are topics challenging collaboration
between movement disorders specialists and dentists.
Several results of the current study suggest a reduced
ability to manage oral hygiene care due to Parkinson’s
disease impairments, which increases as the disease ad-
vances. *is assumption concurs with the ﬁnding of im-
paired dexterity in Parkinson’s disease, predominantly in
advanced stages of the disease [8]. Furthermore, a recent
study proved that ﬁne motor skills in Parkinson’s disease
patients are impaired, predominantly in patients with mild
cognitive impairment [42]. Probably, at a certain, diﬃcult to
predict stage of Parkinson’s disease, patients become de-
pendent on professional or voluntary care providers for
proper daily oral hygiene care. In the current study, 15% of
the Parkinson’s disease patients reported as such. Un-
fortunately, oral hygiene care is generally not prioritized,
either by the professional care providers, or by the patients
themselves. Even providing a guideline to nursing home care
providers and supervised implementation of this guideline
did not result in a general improvement of oral hygiene of
nursing home residents [43]. Subsequently, it was recom-
mended to better integrate professional oral hygiene care
into professional general health care (also in Parkinson’s
disease patients) in order to prevent poor oral health to
become a new geriatric syndrome [44].
A retrospectively ascertained weakness of this study is the
lack of data on social background and lifestyle of both the
Parkinson’s disease patients and the control subjects. Although
the patients were requested to identify a family member or
other close relative who had a similar social background and
lifestyle as a control person, these variables were not ac-
tually assessed. *erefore, some selection bias cannot be
ruled out.
5. Conclusions
*e results of the current study reveal that the Parkinson’s
disease patients had a weakened oral health status and
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reduced oral hygiene care, when compared to an optimally
gender-, age-, social background-, and lifestyle-matched
control group. Additionally, both longer duration of the
disease and more severe disease were associated with more
oral health and oral hygiene care problems, altogether
suggesting that their weakened oral health and reduced oral
hygiene care are due to Parkinson’s disease impairments.
*e authors recommend worldwide multidisciplinary Par-
kinson’s disease medical management teams to pay more
attention to their patients’ oral health including standard
referrals to oral health-care providers, to establish research
of chewing and biting problems, taste disturbance, xero-
stomia, hyposalivation, and drooling in Parkinson’s disease
patients through collaboration of movement disorders
specialists and dentists, and to integrate professional oral
hygiene care into professional general health care for Par-
kinson’s disease patients.
Data Availability
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